GSK and Bayer pushed out from ranking competition, recording low performances

Published: 2016-04-13 10:58:19

Updated: 2016-04-13 10:58:19

In Korea, sales of GSK(GlaxoSmithKline) and Bayer have continuously decreased.

According to 2015 audit reports turned in to the Financial Supervisory Service, GSK and Bayer Korea were reduced in sales last year compared to the year before.

GSK recorded a poor performance of -8.04% as recording KRW 309.299 billion sales last year (KRW 336.351 billion in 2014).

GSK which has been ranked the to...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.